The integration of Artificial Intelligence (AI) in mammography screening has emerged as a promising approach to alleviate the workload pressures faced by radiologists while ensuring high standards of cancer detection accuracy. This study, originating from Denmark, delves into the potential benefits
Ivan Kairatov is a Biopharma expert with a wealth of knowledge in tech and innovation within the industry, bolstered by extensive experience in research and development. Today's interview will delve into the impact of recent administrative changes on VA hospitals, specifically examining the role of
Repligen, an innovative leader in bioprocess technology, has made a strategic move by acquiring essential upstream Process Analytical Technology (PAT) assets from 908 Devices for a total of $70 million. This acquisition should be viewed as more than just a simple addition of technology; it
Chloe Botaine engages Ivan Kairatov, a Biopharma expert with significant knowledge of tech and innovation within the industry, for a detailed discussion on the new AI-based system LILAC (Learning-based Inference of Longitudinal imAge Changes). Topics covered include the system's workings, its
The possibility of creating complex three-dimensional human tissues from diverse biological materials has always been an intriguing concept within medical research. The groundbreaking innovation known as the Electrospider, developed by Bio3DPrinting, a spinoff from Italy's University of Pisa,
Ivan Kairatov is a Biopharma expert with deep knowledge of technology and innovation in the industry, with experience in research and development. Today, we discuss the recent FDA approval of adaptive deep brain stimulation (aDBS) as a new treatment option for Parkinson’s disease. Can you explain
Mirum Pharmaceuticals recently made headlines as they secured FDA approval for Ctexli, also known as chenodiol, as the first treatment for cerebrotendinous xanthomatosis (CTX). CTX, a rare genetic lipid storage disease, affects an estimated 3 to 5 individuals per 100,000. This approval came after a
Human aging is a complex process influenced by a combination of genetic and environmental factors. While the role of genetics has been widely studied, recent research highlights the significant impact of environmental exposures on aging and premature mortality. This article delves into the findings
The intersection of biotechnology and artificial intelligence (AI) is poised to address the inefficiencies and ethical concerns plaguing the current drug development process. One of the most promising innovations in this field is the Bio-AI clinical prediction platform developed by Quris-AI, which
In recent developments, a collaborative research team led by the University of Arizona College of Medicine – Tucson has discovered groundbreaking potential for an FDA-approved osteoporosis drug in the treatment of a rare genetic heart disease. The heart condition in question is dilated
